Cargando…

A plausible involvement of plasmalemmal voltage‐dependent anion channel 1 in the neurotoxicity of 15‐deoxy‐Δ(12,14)‐prostaglandin J(2)

INTRODUCTION: 15‐deoxy‐Δ(12,14)‐prostaglandin J(2) (15d‐PGJ(2)) causes neuronal apoptosis independently of its nuclear receptor, peroxysome‐proliferator activated receptor γ. Its membrane receptor, chemoattractant receptor‐homologous molecule expressed on Th2 cells (CRTH2), did not also mediate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koma, Hiromi, Yamamoto, Yasuhiro, Okamura, Noboru, Yagami, Tatsurou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749624/ https://www.ncbi.nlm.nih.gov/pubmed/33200588 http://dx.doi.org/10.1002/brb3.1866

Ejemplares similares

15-deoxy-Δ(12,14)-prostaglandin J(2) in neurodegenerative diseases and cancers
por: Yagami, Tatsurou, et al.
Publicado: (2017)

Synergistic effects of 15-deoxy Δ(12,14)-prostaglandin J(2) on the anti-tumor activity of doxorubicin in renal cell carcinoma
por: Yamamoto, Yasuhiro, et al.
Publicado: (2016)

Proteomic Identification of Protein Targets for 15-Deoxy-Δ(12,14)-Prostaglandin J(2) in Neuronal Plasma Membrane
por: Yamamoto, Yasuhiro, et al.
Publicado: (2011)

Correction: Proteomic Identification of Protein Targets for 15-Deoxy-Δ(12,14)-Prostaglandin J(2) in Neuronal Plasma Membrane
por: Yamamoto, Yasuhiro, et al.
Publicado: (2011)

Cytotoxicity of 15-Deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent Pathway and the Involvement of the JNK and Akt Pathway in Renal Cell Carcinoma
por: Fujita, Megumi, et al.
Publicado: (2012)

15-deoxy-Δ(12, 14)-prostaglandin J(2) enhances anticancer activities independently of VHL status in renal cell carcinomas
por: Koma, Hiromi, et al.
Publicado: (2019)

Rac1 modification by an electrophilic 15-deoxy Δ(12,14)-prostaglandin J(2) analog
por: Wall, S.B., et al.
Publicado: (2015)

Feedback Control of the Arachidonate Cascade in Osteoblastic Cells by 15-deoxy-Δ(12,14)-Prostaglandin J(2)
por: Ishino, Hidetaka, et al.
Publicado: (2008)

15-Deoxy-Δ(12,14)-Prostaglandin J(2) Inhibits Macrophage Colonization by Salmonella enterica Serovar Typhimurium
por: Buckner, Michelle M. C., et al.
Publicado: (2013)

15-Deoxy-Δ(12,14) Prostaglandin J(2) Reduces the Formation of Atherosclerotic Lesions in Apolipoprotein E Knockout Mice
por: Seno, Takahiro, et al.
Publicado: (2011)

Effects of 15-Deoxy-Δ(12,14)-Prostaglandin J2 (15d-PGJ2) and Rosiglitazone on Human Vδ2(+) T Cells
por: Li, Haishan, et al.
Publicado: (2009)

15-Deoxy-Δ(12,14)-prostaglandin J(2) Induces Apoptosis and Upregulates SOCS3 in Human Thyroid Cancer Cells
por: Trindade-da-Silva, Carlos Antônio, et al.
Publicado: (2016)

15-Deoxy-Δ(12,14)-Prostaglandin J(2) Modifies Components of the Proteasome and Inhibits Inflammatory Responses in Human Endothelial Cells
por: Marcone, Simone, et al.
Publicado: (2016)

The Effects of Co-Treatment of 9-cis-Retinoic Acid and 15-Deoxy-Δ (12,14)-prostaglandin J2 on Microglial Activation
por: Hsu, Pei-Chien, et al.
Publicado: (2011)

Cytotoxic effects of 15-deoxy-Δ12,14-prostaglandin J2 alone and in combination with dasatinib against uterine sarcoma in vitro
por: Kawakita, Takako, et al.
Publicado: (2017)

Changes in the Th1 : Th2 Cytokine Bias in Pregnancy and the Effects of the Anti-Inflammatory Cyclopentenone Prostaglandin 15-Deoxy-Δ(12,14)-Prostaglandin J(2)
por: Sykes, Lynne, et al.
Publicado: (2012)

15-Deoxy-△(12,14)-Prostaglandin J(2) Promotes Resolution of Experimentally Induced Colitis
por: Kim, Wonki, et al.
Publicado: (2021)

15-deoxy-Δ(12,14)-Prostaglandin J(2) inhibits human soluble epoxide hydrolase by a dual orthosteric and allosteric mechanism
por: Abis, Giancarlo, et al.
Publicado: (2019)

15-Deoxy-Δ(12,14)-prostaglandin J(2) Exerts Antioxidant Effects While Exacerbating Inflammation in Mice Subjected to Ureteral Obstruction
por: Nilsson, Line, et al.
Publicado: (2017)

15-deoxy-delta(12,14)-prostaglandin J(2 )induces apoptosis in human articular chondrocytes
por: Masuko-Hongo, K, et al.
Publicado: (2003)

Transcription of Liver X Receptor Is Down-Regulated by 15-Deoxy-Δ(12,14)-Prostaglandin J(2) through Oxidative Stress in Human Neutrophils
por: Alba, Gonzalo, et al.
Publicado: (2012)

15-Deoxy-Δ(12,14)-Prostaglandin J(2) Inhibits Osteolytic Breast Cancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss
por: Kim, Ki Rim, et al.
Publicado: (2015)

15-Deoxy-Δ(12,14)-prostaglandin J2 promotes phosphorylation of eukaryotic initiation factor 2α and activates the integrated stress response
por: Tauber, Devin, et al.
Publicado: (2019)

15-Deoxy-Δ(12,14)-prostaglandin J(2) Induces Epithelial-to-mesenchymal Transition in Human Breast Cancer Cells and Promotes Fibroblast Activation
por: Choi, Jeehye, et al.
Publicado: (2020)

Interleukin-6 Synthesis in Human Chondrocytes Is Regulated via the Antagonistic Actions of Prostaglandin (PG)E(2) and 15-deoxy-Δ(12,14)-PGJ(2)
por: Wang, Pu, et al.
Publicado: (2011)

Sensitive mass spectrometric assay for determination of 15-deoxy-Δ(12,14)-prostaglandin J(2) and its application in human plasma samples of patients with diabetes
por: Morgenstern, Jakob, et al.
Publicado: (2017)

15-Deoxy-Δ(12,14)-prostaglandin J(2) inhibits migration of human thyroid carcinoma cells by disrupting focal adhesion complex and adherens junction
por: Wu, Ya-Chieh, et al.
Publicado: (2017)

STAT3 as a Potential Target for Tumor Suppressive Effects of 15-Deoxy-Δ(12,14)-prostaglandin J(2) in Triple Negative Breast Cancer
por: Kim, Su-Jung, et al.
Publicado: (2021)

15-Deoxy-Δ(12,14)-prostaglandin J(2) as a potential regulator of bone metabolism via PPARγ-dependent and independent pathways: a review
por: Xiong, Zhencheng, et al.
Publicado: (2019)

15-Deoxy-Δ(12,14)-prostaglandin J(2) Upregulates VEGF Expression via NRF2 and Heme Oxygenase-1 in Human Breast Cancer Cells
por: Kim, Eun-Hee, et al.
Publicado: (2021)

15-deoxy-delta12,14-prostaglandin J2 attenuates endothelial-monocyte interaction: implication for inflammatory diseases
por: Prasad, Ratna, et al.
Publicado: (2008)

The PPAR-γ Agonist 15-Deoxy-Δ (12,14)-Prostaglandin J(2) Attenuates Microglial Production of IL-12 Family Cytokines: Potential Relevance to Alzheimer's Disease
por: Xu, Jihong, et al.
Publicado: (2008)

The Eicosapentaenoic Acid Metabolite 15-Deoxy-δ(12,14)-Prostaglandin J(3) Increases Adiponectin Secretion by Adipocytes Partly via a PPARγ-Dependent Mechanism
por: Lefils-Lacourtablaise, Jennifer, et al.
Publicado: (2013)

15-Deoxy-Delta-12,14-Prostaglandin J(2) Inhibits Lung Inflammation and Remodeling in Distinct Murine Models of Asthma
por: Coutinho, Diego S., et al.
Publicado: (2017)

15-Deoxy-Δ(12,14)-ProstaglandinJ2 Regulates Dedifferentiation through Peroxisome Proliferator-Activated Receptor-γ-Dependent Pathway but Not COX-2 Expression in Articular Chondrocytes
por: Lee, Ji-Hye, et al.
Publicado: (2007)

15-Deoxy-Δ(12,14)-Prostaglandin J(2) Inhibits Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury via Redox Pathway
por: Liu, Xin, et al.
Publicado: (2015)

Topical Administration of 15-Deoxy-Δ(12,14)-Prostaglandin J(2) Using a Nonionic Cream: Effect on UVB-Induced Skin Oxidative, Inflammatory, and Histopathological Modifications in Mice
por: Kumagai, Clovis M., et al.
Publicado: (2021)

15-Deoxy-∆-(12,14)-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-γ: Function and Mechanism
por: Li, Jingjing, et al.
Publicado: (2019)

Effect of 15-Deoxy-∆(12,14)-prostaglandin J(2) Nanocapsules on Inflammation and Bone Regeneration in a Rat Bone Defect Model
por: Tang, Qi, et al.
Publicado: (2017)

15-Deoxy-Δ(12,14)-prostaglandin J(2 )inhibits IL-1β-induced cyclooxygenase-2 expression in human synovial fibroblasts through a histone deacetylase-independent mechanism
por: Farrajota, K, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_j99n241os4p2bhd0dv7fhdbib6